Delcath Systems, Inc.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…

Medical - Specialties

US, New York [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Officers & BofD Beta

All directors and officers of Delcath Systems, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).

Form 3/4/5
Proxy DEF-14A

Total Compensation

Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.

- No data, only available if we have DEF 14A compensations in place -

Officers

Name & Position	Research
Michel Gerard J CHIEF EXECUTIVE OFFICER Also inside the BofD	Transactions Compensations Speech	10/23/24 [Form 4]
Rook Martha S. CHIEF OPERATING OFFICER	Transactions Compensations Speech	03/20/24 [Form 4]
Vukovic Vojo CHIEF MEDICAL OFFICER	Transactions Compensations Speech	03/19/24 [Form 4]
Pennell Sandra SVP OF FINANCE, PFO AND PAO	Transactions Compensations Speech	03/19/24 [Form 4]
Muir Kevin GM INTERVENTIONAL ONCOLOGY	Transactions Compensations Speech	03/19/24 [Form 4]
Hoffman David L. GEN'L COUNSEL, CCO & SECY	Transactions Compensations Speech	03/19/24 [Form 4]
Dias Anthony VP FINANCE	Transactions Compensations Speech	02/20/24 [Form 4]
Purpura John CHIEF OPERATING OFFICER	Transactions Compensations Speech	01/26/24 [Form 4]
John Johnny SVP CLINICAL DEV & MED AFFAIRS	Transactions Compensations Speech	01/26/24 [Form 4]

Board of Directors (BofD)

Name & Position	Research
Salamon Steven A J Director	Transactions Compensations Speech	12/27/24 [Form 4]
Aharon Gil Director	Transactions Compensations Speech	12/26/24 [Form 4]
Sylvester John Richard Director	Transactions Compensations Speech	05/28/24 [Form 4]
Martell Bridget A Director	Transactions Compensations Speech	05/28/24 [Form 4]
Stoll Roger G Phd Director	Transactions Compensations Speech	05/28/24 [Form 4]